Accipiter Capital Management as of March 31, 2012
Portfolio Holdings for Accipiter Capital Management
Accipiter Capital Management holds 18 positions in its portfolio as reported in the March 2012 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Health Management Associates | 20.7 | $24M | 3.6M | 6.72 | |
Hca Holdings (HCA) | 9.7 | $11M | 460k | 24.74 | |
Healthsouth | 8.3 | $9.8M | 478k | 20.48 | |
Teva Pharmaceutical Industries (TEVA) | 8.0 | $9.4M | 208k | 45.06 | |
WellPoint | 7.5 | $8.8M | 119k | 73.80 | |
Stewart Enterprises | 5.9 | $7.0M | 1.1M | 6.07 | |
Sanofi-Aventis SA (SNY) | 5.9 | $6.9M | 179k | 38.75 | |
CIGNA Corporation | 5.6 | $6.5M | 132k | 49.25 | |
Boston Scientific Corporation (BSX) | 5.1 | $6.0M | 1.0M | 5.98 | |
Vivus | 4.8 | $5.6M | 250k | 22.36 | |
BioMarin Pharmaceutical (BMRN) | 4.7 | $5.5M | 160k | 34.25 | |
Five Star Quality Care | 4.2 | $5.0M | 1.5M | 3.41 | |
Cutera (CUTR) | 3.1 | $3.7M | 429k | 8.55 | |
Community Health Systems (CYH) | 2.5 | $3.0M | 134k | 22.24 | |
LifePoint Hospitals | 1.7 | $2.0M | 52k | 39.44 | |
Aetna | 1.5 | $1.8M | 35k | 50.15 | |
Transcept Pharmaceuticals | 0.6 | $673k | 64k | 10.52 | |
MELA Sciences | 0.1 | $143k | 32k | 4.48 |